Literature DB >> 20524084

Primary esophageal CD30-positive ALK-positive anaplastic large cell lymphoma: a case report and literature review.

Ning Wu1, Liewen Pang, Zhiming Chen, Yiqing Wang, Qinyun Ma, Gang Chen, Ji Chen, Jiechun Huang.   

Abstract

PURPOSE: To introduce a case of primary esophageal CD30-positive ALK-positive anaplastic large cell lymphoma (ALCL) and discuss its diagnosis and treatment.
METHODS: Esophagectomy was done for a 37-year-old male with a submucosal lesion after a frozen section failed to give a definite diagnosis. Samples were sent for hematoxylin-eosin staining and immunohistochemical analysis. Six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy were given and the patient was followed up.
RESULTS: The operation was uneventful. Postoperative pathologic and immunohistochemical examination yielded a diagnosis of primary CD30-positive and ALK-positive ALCL of the esophagus. The patient was in complete remission at the 14-month follow-up.
CONCLUSIONS: ALCL of the esophagus should be considered in the differential diagnosis of esophageal submucosal lesions. Biopsy through either esophagoscopy or surgical exploration, chemotherapy, and radiotherapy can be chosen for long-term survival.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20524084     DOI: 10.1007/s12029-010-9147-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  10 in total

Review 1.  CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Authors:  H Stein; H D Foss; H Dürkop; T Marafioti; G Delsol; K Pulford; S Pileri; B Falini
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Lymphosarcoma: a review of 1269 cases.

Authors:  S A ROSENBERG; H D DIAMOND; B JASLOWITZ; L F CRAVER
Journal:  Medicine (Baltimore)       Date:  1961-02       Impact factor: 1.889

3.  Primary Ki-1 (CD 30)-positive, large cell, anaplastic lymphoma of the esophagus.

Authors:  J M Pearson; A Borg-Grech
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

4.  Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.

Authors:  Mary Ann Thompson; Jennifer Stumph; Sarah E Henrickson; Andreas Rosenwald; Qifu Wang; Sandy Olson; Stephen J Brandt; Jeremy Roberts; Xueqiong Zhang; Yu Shyr; Marsha C Kinney
Journal:  Hum Pathol       Date:  2005-05       Impact factor: 3.466

5.  CD30 (Ki-1)-positive, anaplastic large cell lymphoma mimicking gastrointestinal carcinoma.

Authors:  C W Ross; C A Hanson; B Schnitzer
Journal:  Cancer       Date:  1992-11-15       Impact factor: 6.860

6.  Primary malignant lymphoma of the esophagus. A case report.

Authors:  T Doki; S Hamada; H Murayama; H Suenaga; Y Sannohe
Journal:  Endoscopy       Date:  1984-09       Impact factor: 10.093

7.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

8.  Primary oesophageal Ki (CD30)-positive ALK+ anaplastic large cell lymphoma of T-cell phenotype.

Authors:  H Yaakup; I Sagap; S A Fadilah
Journal:  Singapore Med J       Date:  2008-10       Impact factor: 1.858

9.  Requirement for cyclin D3 in lymphocyte development and T cell leukemias.

Authors:  Ewa Sicinska; Iannis Aifantis; Laurent Le Cam; Wojciech Swat; Christine Borowski; Qunyan Yu; Adolfo A Ferrando; Steven D Levin; Yan Geng; Harald von Boehmer; Piotr Sicinski
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

10.  Gastrointestinal involvement in non-Hodgkin's lymphoma.

Authors:  R Herrmann; A M Panahon; M P Barcos; D Walsh; L Stutzman
Journal:  Cancer       Date:  1980-07-01       Impact factor: 6.860

  10 in total
  6 in total

1.  Primary esophageal non-Hodgkin's lymphoma: demographics, clinical characteristics, histopathologic types, and survival in 179 patients from the SEER program and systematic review of the literature.

Authors:  Andrea Carolina Quiroga-Centeno; Ileana Rocio Bautista-Parada; Luis F Tapias; Sergio Alejandro Gómez-Ochoa
Journal:  Esophagus       Date:  2021-04-20       Impact factor: 4.230

Review 2.  Primary Esophageal Extranasal NK/T Cell Lymphoma With Biphasic Morphology: A Case Report and Literature Review.

Authors:  Zi-Yin Ye; Qing-Hua Cao; Fang Liu; Xiao-Fang Lu; Shu-Rong Li; Chang-Zhao Li; Shao-Hong Chen
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

3.  ALK-positive anaplastic large cell lymphoma presenting multiple lymphomatous polyposis: A case report and literature review.

Authors:  Makoto Saito; Koh Izumiyama; Reiki Ogasawara; Akio Mori; Takeshi Kondo; Masanori Tanaka; Masanobu Morioka; Kencho Miyashita; Mishie Tanino
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

4.  Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report.

Authors:  Yuto Hozaka; Ken Sasaki; Takuro Nishikawa; Shun Onishi; Masahiro Noda; Yusuke Tsuruda; Yasuto Uchikado; Yoshiaki Kita; Takaaki Arigami; Shinichiro Mori; Kosei Maemura; Satoshi Ieiri; Yoshifumi Kawano; Shoji Natsugoe; Takao Ohtsuka
Journal:  Surg Case Rep       Date:  2021-02-05

5.  Primary Esophageal Lymphoma: A Rare Entity.

Authors:  Sanjeev Sachdeva; Arpan Jain; Ashok Dalal; A S Puri
Journal:  GE Port J Gastroenterol       Date:  2021-05-27

6.  PAX-5 positive anaplastic large cell lymphoma presenting by dysphagia; a case report.

Authors:  Negar Azarpira; Akbar Safaie; Ahmad Monabati; Masudd Hosseinzadeh; Sadat Noori; Maryam Moini; Alireza Rahimi; Tahereh Heidari; Marjan Rahsaz
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.